Skip to content

Public FDA record

Z-0025-2025: Beckman Coulter Dxl 9000 Access Immunoassay Analyzer, REF #C11137. An in vitro diagnostic device used for

Recall record Z-0025-2025 for Beckman Coulter, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0025-2025
Company in FDA record
Beckman Coulter, Inc.
FDA classification date
Oct 7, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

When the DxI 9000 Access Immunoassay Analyzer with system software version 1.16.2 and prior is configured to automatically request a calibration order, the instrument can process the order with expired calibrator material. If the calibration curve is generated with an expired calibration material lot, this may lead to a hazardous situation of erroneously high or low patient results reported to the physicians.

Source facts

Action
The recalling firm issued letters dated 4/12/2024 on 4/18/2024 via first class mail. The letter described the issue, the impact, and actions to be taken, which included: (a) Verify the calibrator material expiration date before ordering a calibration on the analyzer; (b) Cancel calibration orders after the calibrator lot material expires. Instructions for canceling a calibration order are provided in the device help system or in the Calibration section of the IFU; (c) Repeat any test results generated from a calibration curve that used expired calibrator lot material. The resolution provided was that the firm is investigating the root cause of the issue and will implement the correction with a future software release. A service representative will contact the consignee to schedule the software upgrade when it is available. The letter is to be shared with laboratory staff and retained as part of the laboratory Quality System documentation. If the device has been forwarded to another laboratory, the consignee is to provide a copy of the letter to that laboratory. A Response Form was enclosed for completion and return within 10 days to assure the information has been received.
Initiated
2024-04-18
Root cause
Software design
Distribution
Distribution was made to FL, GA, IN, KS, NH, NJ, OK, PA, and TX. There was government distribution but no military distribution. Foreign distribution was made to Australia, Austria, Belgium, Brazil, Croatia, Czechia, Egypt, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Province of China, and United Kingdom of Great Britain and Northern Ireland.
Recall number
Z-0025-2025
Recall status
Open, Classified
CDRH record ID
209773
FDA classified
2024-10-07
Recall event number
95227

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗